News & Events
October 24, 2018 - October 27, 2018
11th Clinical Trials on Alzheimer’s Disease (CTAD)The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an important annual scientific meeting where latest developments and research results from clinical Alzheimer disease trials are shared and discussed. Researchers and participants from pharma, academia, patent-advocacy organizations and other groups are coming together in Barcelona, Spain, between October 24th and 27th. Each year, on behalf......
October 7, 2018 - October 10, 2018
9th Annual Conference of Pharmacometrics (ACoP9)The ninth Annual Conference of Pharmacometrics (ACoP9) is the annual scientific meeting of the International Society of Pharmacometrics. More than 650 researchers and participants from pharma, academia, and non-government organizations attended ACoP9 in San Diego between October 6th and 11th to exchange the latest research and application of quantitative methods to pharmaceutics. Members of the......
September 26, 2017
Coalition Against Major Diseases 2017 Annual Meeting and Regulatory Science WorkshopSeptember 26, 2017 Overview and Objectives: The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase the efficiency of the development process of new treatments for Alzheimer disease (AD) and related dementias. The annual meeting, which is open to the public, brings......
May 9, 2017 - May 10, 2017
Advancing CDISC Standards for Biosensors Assessments in Clinical Drug Trials: 2017 Biometric Monitoring Device WorkshopMay 9-10, 2017 Bethesda North Marriott Hotel and Conference Center Bethesda, MD Meeting Overview/Objectives: Review contemporary use cases for mobile biosensor assessments of three domains of function that are impacted by Neurological Disorders (mobility/sleep/cognitive performance). Review & address key regulatory considerations for various Contexts-of-Use. Convene CDISC Standard experts to advance a plan that enables data......
March 10, 2017
Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards DevelopmentMarch 10, 2017 Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ Overview and Objectives The Coalition Against Major Diseases (CAMD), a consortium within the Critical Path Institute, is focused on accelerating the regulatory sciences required to advance innovative treatments for Alzheimer Disease and related neurodegenerative diseases with impaired cognition and function. In collaboration with......